Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Expert Review of Pharmacoeconomics & Outcomes Research|March 6, 2026
Duration changes and decision-making in DCETTO: evidence from SF-6Dv2Hosein Ameri, Thomas G Poder
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 28, 2024
Comparison of four approaches in eliciting health state utilities with SF-6Dv2Hosein Ameri, Thomas G Poder
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 18, 2026
Impact of Smoothing and Modeling Approach on Quality-Adjusted Life Expectancy EstimatesHosein Ameri, Thomas G Poder
International Journal of Health Policy and Management|December 2, 2024
Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, CanadaHosein Ameri, Thomas G Poder
Social Science & Medicine (1982)|December 25, 2024
A new SF-6Dv2 value set based on a hybrid model using SG, cTTO, and DCE dataThomas G Poder, Hosein Ameri
Social Science & Medicine (1982)|August 17, 2025
Comparison of methods for anchoring latent values on the full health-dead utility scaleThomas G Poder, Hosein Ameri
Frontiers in Oncology|December 26, 2022
Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in IranNasrin Moradi, Thomas G Poder, Hossein Safari, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 23, 2025
EQ-5D-5L Iranian population norms derived from the local value set during the COVID-19 pandemicSomayeh Afshari, Thomas G Poder, Rajabali Daroudi, et al.
Pageof 15